Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td

Tetanus

Double Blind, Randomized Phase III Study to Evaluate the Immunogenicity and Safety of ‘BR-TD-1001’ Administered Intramuscularly in Healthy Children Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses Tdap Vaccine Safety for Plasma Donors Antitetanus Vaccination for People Older Than 65 Years. Multicenter Study of Tetanus Patients in Fujian Province of China The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine Pneumonia in Tetanus Study Intrathecal Tetanus Immunoglobulin to Treat Tetanus Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels